Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?

Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?

LINKED CONTENT This article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2024-11, Vol.60 (10), p.1449-1450
Hauptverfasser: Ebrahimi, Fahim, Forss, Anders
Format: Artikel
Sprache:eng
Schlagworte:
Advanced glycosylation end products
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1450
container_issue 10
container_start_page 1449
container_title Alimentary pharmacology & therapeutics
container_volume 60
creator Ebrahimi, Fahim
Forss, Anders
description LINKED CONTENT This article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218
doi_str_mv 10.1111/apt.18240
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3117618786</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3117618786</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2780-4054336e22017eb108b36f785ff830412b3933e395b8d1effcb89acda870cd173</originalsourceid><addsrcrecordid>eNp1kMFO3DAURa0KVKa0i_4AssSGLgJ-dmI7bNBAgSIhtQu6jhz7BYw8yRA7oNnxCXwjX1LDUBaV6s3bHB1dH0K-AtuH_A7MMu2D5iX7QGYgZFVwJuQGmTEu64JrEFvkU4y3jDGpGP9ItkRdQqVAzMjNqfNpGL0Jh3Tu7k1v0dHrsLIm-aGn2Du6HAc32RTp8-MTNdR5TGZcUTuF5egT7YaRXhx_p76n6QbpNfaYvDUhrGicosVl8m3Ao89kszMh4pe3u01-n51enfwoLn-eX5zMLwvLlWZFyapSCImcM1DYAtOtkJ3SVddpwUrgraiFQFFXrXaAXWdbXRvrjFbMOlBim-ytvXn23YQxNQufV4Rgehym2AgAJUErLTO6-w96O0xjn9e9ULUSXHLI1Lc1ZcchxhG7Jn97kQs0wJqX_E3O37zmz-zOm3FqF-jeyb-9M3CwBh58wNX_Tc3819Va-QeYiY5T</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3119732621</pqid></control><display><type>article</type><title>Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ebrahimi, Fahim ; Forss, Anders</creator><creatorcontrib>Ebrahimi, Fahim ; Forss, Anders</creatorcontrib><description>LINKED CONTENT This article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218</description><identifier>ISSN: 0269-2813</identifier><identifier>ISSN: 1365-2036</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.18240</identifier><identifier>PMID: 39415713</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Advanced glycosylation end products</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2024-11, Vol.60 (10), p.1449-1450</ispartof><rights>2024 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2024 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2780-4054336e22017eb108b36f785ff830412b3933e395b8d1effcb89acda870cd173</cites><orcidid>0000-0002-1906-4982</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.18240$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.18240$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39415713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ebrahimi, Fahim</creatorcontrib><creatorcontrib>Forss, Anders</creatorcontrib><title>Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>LINKED CONTENT This article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218</description><subject>Advanced glycosylation end products</subject><issn>0269-2813</issn><issn>1365-2036</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kMFO3DAURa0KVKa0i_4AssSGLgJ-dmI7bNBAgSIhtQu6jhz7BYw8yRA7oNnxCXwjX1LDUBaV6s3bHB1dH0K-AtuH_A7MMu2D5iX7QGYgZFVwJuQGmTEu64JrEFvkU4y3jDGpGP9ItkRdQqVAzMjNqfNpGL0Jh3Tu7k1v0dHrsLIm-aGn2Du6HAc32RTp8-MTNdR5TGZcUTuF5egT7YaRXhx_p76n6QbpNfaYvDUhrGicosVl8m3Ao89kszMh4pe3u01-n51enfwoLn-eX5zMLwvLlWZFyapSCImcM1DYAtOtkJ3SVddpwUrgraiFQFFXrXaAXWdbXRvrjFbMOlBim-ytvXn23YQxNQufV4Rgehym2AgAJUErLTO6-w96O0xjn9e9ULUSXHLI1Lc1ZcchxhG7Jn97kQs0wJqX_E3O37zmz-zOm3FqF-jeyb-9M3CwBh58wNX_Tc3819Va-QeYiY5T</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Ebrahimi, Fahim</creator><creator>Forss, Anders</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1906-4982</orcidid></search><sort><creationdate>202411</creationdate><title>Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?</title><author>Ebrahimi, Fahim ; Forss, Anders</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2780-4054336e22017eb108b36f785ff830412b3933e395b8d1effcb89acda870cd173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Advanced glycosylation end products</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ebrahimi, Fahim</creatorcontrib><creatorcontrib>Forss, Anders</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ebrahimi, Fahim</au><au>Forss, Anders</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2024-11</date><risdate>2024</risdate><volume>60</volume><issue>10</issue><spage>1449</spage><epage>1450</epage><pages>1449-1450</pages><issn>0269-2813</issn><issn>1365-2036</issn><eissn>1365-2036</eissn><abstract>LINKED CONTENT This article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39415713</pmid><doi>10.1111/apt.18240</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-1906-4982</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2024-11, Vol.60 (10), p.1449-1450
issn 0269-2813
1365-2036
1365-2036
language eng
recordid cdi_proquest_miscellaneous_3117618786
source Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Advanced glycosylation end products
title Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T06%3A49%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial:%20Advanced%20glycation%20end%20products%20%E2%80%90%20a%20dietary%20culprit%20for%20IBD%20in%20the%20genetically%20susceptible?&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Ebrahimi,%20Fahim&rft.date=2024-11&rft.volume=60&rft.issue=10&rft.spage=1449&rft.epage=1450&rft.pages=1449-1450&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.18240&rft_dat=%3Cproquest_cross%3E3117618786%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3119732621&rft_id=info:pmid/39415713&rfr_iscdi=true